These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA; J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456 [TBL] [Abstract][Full Text] [Related]
47. Impact of age and duration of growth hormone therapy in children with Turner syndrome. Ross J; Lee PA; Gut R; Germak J Horm Res Paediatr; 2011; 76(6):392-9. PubMed ID: 22156541 [TBL] [Abstract][Full Text] [Related]
48. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952 [TBL] [Abstract][Full Text] [Related]
49. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853 [TBL] [Abstract][Full Text] [Related]
50. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial. Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015 [TBL] [Abstract][Full Text] [Related]
51. [Identification and characterization of marker chromosome in Turner syndrome]. Tan YQ; Cheng DH; DI YF; Li LY; Lu GX Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):679-82. PubMed ID: 18241543 [TBL] [Abstract][Full Text] [Related]
52. Adult Height in 299 Patients with Turner Syndrome with or without Growth Hormone Therapy: Results and Literature Review. Dantas NCB; Braz AF; Malaquias A; Lemos-Marini S; Arnhold IJP; Silveira ER; Antonini SR; Guerra-Junior G; Mendonca B; Jorge A; Scalco RC Horm Res Paediatr; 2021; 94(1-2):63-70. PubMed ID: 34134112 [TBL] [Abstract][Full Text] [Related]
53. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791 [TBL] [Abstract][Full Text] [Related]
54. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094 [TBL] [Abstract][Full Text] [Related]
55. [Analysis of the small supernumerary marker chromosome in Turner syndrome with 45, X/46, X, + mar karyotype]. Ye ZC; Cai JG; Zhu XY; Zhao R; He XY; Zhong Y; Liu KX; Zhu YM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):461-4. PubMed ID: 20017317 [TBL] [Abstract][Full Text] [Related]
56. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781 [TBL] [Abstract][Full Text] [Related]
57. [Marker chromosome analysis in Chinese patients with Turner syndrome by fluorescence in situ hybridization]. Liang Y; Luo XP Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):435-7. PubMed ID: 16086285 [TBL] [Abstract][Full Text] [Related]
58. Descriptive analyses of Turner syndrome: 49 cases in Tunisia. Elleuch M; Mnif Feki M; Kammoun M; Charfi N; Rekik N; Bouraoui A; Kammoun T; Belguith N; Kammoun H; Sfar MT; Hachicha M; Abid M Ann Endocrinol (Paris); 2010 Mar; 71(2):111-6. PubMed ID: 20153455 [TBL] [Abstract][Full Text] [Related]
59. X chromosome parental origin and aortic stiffness in turner syndrome. Abd-Elmoniem KZ; Bakalov VK; Matta JR; Muldoon N; Hanover JA; Bondy CA; Gharib AM Clin Endocrinol (Oxf); 2014 Sep; 81(3):467-70. PubMed ID: 24796499 [TBL] [Abstract][Full Text] [Related]